We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Baxter’s Generic Anesthetic Prevails In Patent Dispute With Abbott Labs

Law360 (September 26, 2005, 12:00 AM EDT) -- Baxter Pharmaceuticals has won a court’s green light to begin marketing a generic version of the popular anesthetic Ultane after prevailing in a patent infringement lawsuit brought by drug originator Abbott...
To view the full article, register now.